SCHEMBL29414672

SCHEMBL29414672

Cc1ccc(S(=O)(=O)n2cc(C(C)C)c3nc(Cc4c(C)cc(OCc5ccccc5)cc4C)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD4 P01730 2/20 0.42
HTR6 P50406 3/20 0.40
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ALK Q9UM73 1/20 0.37
AR P10275 1/20 0.37
CYP19A1 P11511 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP7 P09237 1/20 0.35
MMP9 P14780 1/20 0.35
MMP12 P39900 1/20 0.35
MMP14 P50281 1/20 0.35
MMP15 P51511 1/20 0.35
MMP16 P51512 1/20 0.35
MMP26 Q9NRE1 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22632610 1.00 CD4 (0.42) CD4HTR6HDAC1HDAC6ALK
SCHEMBL29414674 1.00 CD4 (0.42) CD4HTR6HDAC1HDAC6ALK
SCHEMBL30711130 0.90 CD4 (0.37) CD4HTR6HDAC1HDAC6ALK
SCHEMBL29414841 0.89 HTR6 (0.35) CD4HTR6HDAC1HDAC6
SCHEMBL31258414 0.88 CD4 (0.42) CD4HTR6HDAC1HDAC6ALK
SCHEMBL22632786 0.88 CD4 (0.42) CD4HTR6HDAC1HDAC6ALK
SCHEMBL31405725 0.87 THRB (0.34) CD4HTR6AR
SCHEMBL31405692 0.85 CD4 (0.42) CD4HTR6HDAC1HDAC6ALK
SCHEMBL22632905 0.85 ALK (0.40) HTR6ALKCYP19A1L3MBTL1
SCHEMBL22632943 0.85 HTR6 (0.34) HTR6ALKCYP19A1L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036699-A THR-beta modulators and methods of use thereof 阿利戈斯治疗公司 2026-05-15 CN disclosed
WO-2024260309-A1 THR-β RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE METHOD THEREFOR 西威埃医药技术(上海)有限公司 2024-12-26 WO disclosed
EP-3965884-A1 MODULATORS OF THR-BETA AND METHODS OF USE THEREOF Aligos Therapeutics, Inc. (US) 2022-03-16 EP disclosed